Escherichia coli strain Nissle 1917 (Mutaflor®,) enteric coated hard capsule finished product (probiotic)

Product description

E. coli strain Nissle 1917 is of human origin. It fulfills all microbiological and molecular biological safety requirements.
In the field of gastgroenterology it is
  • used maintain the remission stage of ulcerative colitis
  • and to treat patients with chronic constipation.

The product quality is amongs others, characterized by its microbiological purity and the defined high number of viable cell in each chard capsule.
The pharmaceutical form of a enteric coated hard caplsule allows, that high numbers of E. coli Nissle bacteria can reach the intestinal tract in a viable state.
CTD is available.

Live Biotherapeutic Product (LBP)
Read more

Specifications

Categories APIsProbiotics; APIs
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from Germany
Measured In mg; Pieces
Selling Points Digestive Health; Price; Product Features; Quality Service
Show more specifications

More products from Pharma Zentrale GmbH

View all our products (27)

Products from other suppliers

Escherichia coli strain Nissle 1917 (Mutaflor®,) enteric coated hard capsule finished product (probiotic)

Contact information

Address

Telephone

Website

View all contact information